PDIA3 epitope-driven immune autoreactivity contributes to hepatic damage in type 2 diabetes

A diet rich in saturated fat and carbohydrates causes low-grade chronic inflammation in several organs, including the liver, ultimately driving nonalcoholic steatohepatitis. In this setting, environment-driven lipotoxicity and glucotoxicity induce liver damage, which promotes dendritic cell activation and generates a major histocompatibility complex class II (MHC-II) immunopeptidome enriched with peptides derived from proteins involved in cellular metabolism, oxidative phosphorylation, and the stress responses. Here, we demonstrated that lipotoxicity and glucotoxicity, as driven by a high-fat and high-fructose (HFHF) diet, promoted MHC-II presentation of nested T and B cell epitopes from protein disulfide isomerase family A member 3 (PDIA3), which is involved in immunogenic cell death. Increased MHC-II presentation of PDIA3 peptides was associated with antigen-specific proliferation of hepatic CD4+ immune infiltrates and isotype switch of anti-PDIA3 antibodies from IgM to IgG3, indicative of cellular and humoral PDIA3 autoreactivity. Passive transfer of PDIA3-specific T cells or PDIA3-specific antibodies also exacerbated hepatocyte death, as determined by increased hepatic transaminases detected in the sera of mice subjected to an HFHF but not control diet. Increased humoral responses to PDIA3 were also observed in patients with chronic inflammatory liver conditions, including autoimmune hepatitis, primary biliary cholangitis, and type 2 diabetes. Together, our data indicated that metabolic insults caused by an HFHF diet elicited liver damage and promoted pathogenic immune autoreactivity driven by T and B cell PDIA3 epitopes. Description Metabolic insults elicit epitope-dependent immune autoreactivity to PDIA3, aggravating hepatic damage in type 2 diabetes. Livers beware T and B cells! So-called “American,” high-fat and high-sugar, diets are known to contribute to chronic inflammation in the liver and subsequent autoimmune reactions, yet the immune responses behind this phenomenon are not well characterized. Here, Clement et al. identified PDIA3, a protein involved in immunogenic cell death, as a peptide presented via MHC-II that led to pathogenic T and B cell responses in mice given a high-fat, high-glucose diet. PDIA3-specific T cells and PDIA3-specific antibodies were sufficient to induce liver toxicity. Anti-PDIA3 was detected at high levels in the serum of patients with chronic inflammatory liver conditions. Thus, the American diet induces liver damage through PDIA3-specific T and B cells in mice.

[1]  E. Gautier,et al.  Immune cell-mediated features of non-alcoholic steatohepatitis , 2021, Nature Reviews Immunology.

[2]  L. Galluzzi,et al.  Pleiotropic consequences of metabolic stress for the major histocompatibility complex class II molecule antigen processing and presentation machinery. , 2021, Immunity.

[3]  F. Tacke,et al.  Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis: mechanisms, treatment and prevention , 2020, Annals of translational medicine.

[4]  F. Marincola,et al.  Consensus guidelines for the definition, detection and interpretation of immunogenic cell death , 2020, Journal for ImmunoTherapy of Cancer.

[5]  J. Boyer,et al.  Primary Biliary Cholangitis: 2018 Practice Guidance From the American Association for the Study of Liver Diseases , 2020, Clinical Liver Disease.

[6]  F. Beguinot,et al.  Chronic Adipose Tissue Inflammation Linking Obesity to Insulin Resistance and Type 2 Diabetes , 2020, Frontiers in Physiology.

[7]  M. Manns,et al.  Diagnosis and Management of Autoimmune Hepatitis in Adults and Children: 2019 Practice Guidance and Guidelines From the American Association for the Study of Liver Diseases , 2019, Hepatology.

[8]  P. Bozza,et al.  Fat, fight, and beyond: The multiple roles of lipid droplets in infections and inflammation , 2019, Journal of leukocyte biology.

[9]  B. Nikolajczyk,et al.  Tissue Immune Cells Fuel Obesity-Associated Inflammation in Adipose Tissue and Beyond , 2019, Front. Immunol..

[10]  V. De Rosa,et al.  Type 2 Diabetes: How Much of an Autoimmune Disease? , 2019, Front. Endocrinol..

[11]  J. Boyer,et al.  Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases , 2018, Hepatology.

[12]  G. Frühbeck,et al.  NLRP3 Inflammasome: A Possible Link Between Obesity-Associated Low-Grade Chronic Inflammation and Colorectal Cancer Development , 2018, Front. Immunol..

[13]  E. Engleman,et al.  Insulin Receptor-Mediated Stimulation Boosts T Cell Immunity during Inflammation and Infection. , 2018, Cell metabolism.

[14]  C. O'Donnell,et al.  Adipose tissue-derived free fatty acids initiate myeloid cell accumulation in mouse liver in states of lipid oversupply. , 2018, American journal of physiology. Endocrinology and metabolism.

[15]  L. Galluzzi,et al.  Linking cellular stress responses to systemic homeostasis , 2018, Nature Reviews Molecular Cell Biology.

[16]  G. Hirschfield,et al.  EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. , 2017, Journal of hepatology.

[17]  W. Chapman,et al.  Type I interferon responses drive intrahepatic T cells to promote metabolic syndrome , 2017, Science Immunology.

[18]  L. Zitvogel,et al.  Immunogenic cell death in cancer and infectious disease , 2016, Nature Reviews Immunology.

[19]  Y. Abed,et al.  Obesity and inflammation: the linking mechanism and the complications , 2016, Archives of medical science : AMS.

[20]  Valerio Zolla,et al.  The Dendritic Cell Major Histocompatibility Complex II (MHC II) Peptidome Derives from a Variety of Processing Pathways and Includes Peptides with a Broad Spectrum of HLA-DM Sensitivity* , 2016, The Journal of Biological Chemistry.

[21]  P. Arner,et al.  Increased fat cell size: a major phenotype of subcutaneous white adipose tissue in non-obese individuals with type 2 diabetes , 2016, Diabetologia.

[22]  Michael N. Alonso,et al.  Adaptive Immunity and Antigen-Specific Activation in Obesity-Associated Insulin Resistance , 2015, Mediators of inflammation.

[23]  A. Urbanska,et al.  Hydrodynamic size-based separation and characterization of protein aggregates from total cell lysates , 2014, Nature Protocols.

[24]  J. Betts,et al.  The impact of adiposity on adipose tissue-resident lymphocyte activation in humans , 2014, International Journal of Obesity.

[25]  J. Drenth EASL Clinical Practice Guidelines: Autoimmune hepatitis. , 2015, Journal of hepatology.

[26]  Daniel Winer,et al.  T-Cell Profile in Adipose Tissue Is Associated With Insulin Resistance and Systemic Inflammation in Humans , 2014, Arteriosclerosis, thrombosis, and vascular biology.

[27]  J. Perrard,et al.  Attenuated adipose tissue and skeletal muscle inflammation in obese mice with combined CD4+ and CD8+ T cell deficiency. , 2014, Atherosclerosis.

[28]  J. Perrard,et al.  Essential Role of CD11a in CD8+ T-Cell Accumulation and Activation in Adipose Tissue , 2014, Arteriosclerosis, thrombosis, and vascular biology.

[29]  C. V. van Nieuwkerk,et al.  Auto immune hepatitis. , 2016, World journal of gastroenterology.

[30]  D. Winer,et al.  The adaptive immune system as a fundamental regulator of adipose tissue inflammation and insulin resistance , 2012, Immunology and cell biology.

[31]  D. Stolz,et al.  Dendritic Cells Promote Macrophage Infiltration and Comprise a Substantial Proportion of Obesity-Associated Increases in CD11c+ Cells in Adipose Tissue and Liver , 2012, Diabetes.

[32]  J. Olefsky,et al.  Increased Macrophage Migration Into Adipose Tissue in Obese Mice , 2012, Diabetes.

[33]  Michael N. Alonso,et al.  B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies , 2011, Nature Medicine.

[34]  R. Locksley,et al.  Eosinophils Sustain Adipose Alternatively Activated Macrophages Associated with Glucose Homeostasis , 2011, Science.

[35]  Dorothy D. Sears,et al.  Fat-induced inflammation unchecked. , 2010, Cell metabolism.

[36]  K. Clément,et al.  Short-Term Overfeeding May Induce Peripheral Insulin Resistance Without Altering Subcutaneous Adipose Tissue Macrophages in Humans , 2010, Diabetes.

[37]  F. Greenway,et al.  Obesity Increases the Production of Proinflammatory Mediators from Adipose Tissue T Cells and Compromises TCR Repertoire Diversity: Implications for Systemic Inflammation and Insulin Resistance , 2010, The Journal of Immunology.

[38]  L. Heilbronn,et al.  IL-6, IL-8 and IL-10 Levels in Healthy Weight and Overweight Children , 2010, Hormone Research in Paediatrics.

[39]  S. Imaoka,et al.  LKM-1 sera from autoimmune hepatitis patients that recognize ERp57, carboxylesterase 1 and CYP2D6. , 2010, Drug metabolism and pharmacokinetics.

[40]  E. Engleman,et al.  Obesity predisposes to Th17 bias , 2009, European journal of immunology.

[41]  R. Nagai,et al.  Adipose tissue inflammation in obesity and metabolic syndrome. , 2009, Discovery medicine.

[42]  J. Zieleński,et al.  Normalization of Obesity-Associated Insulin Resistance through Immunotherapy: CD4+ T Cells Control Glucose Homeostasis , 2009, Nature Medicine.

[43]  P. van Endert,et al.  Mechanisms of pre‐apoptotic calreticulin exposure in immunogenic cell death , 2009, The EMBO journal.

[44]  S. Yusuf,et al.  Lipid profile, plasma apolipoproteins, and risk of a first myocardial infarction among Asians: an analysis from the INTERHEART Study. , 2009, Journal of the American College of Cardiology.

[45]  L. Zitvogel,et al.  The co-translocation of ERp57 and calreticulin determines the immunogenicity of cell death , 2008, Cell Death and Differentiation.

[46]  A. Remppis,et al.  Absence of Auto‐Antibodies against Cardiac Troponin I Predicts Improvement of Left Ventricular Function after Acute Myocardial Infarction , 2008, European heart journal.

[47]  Herbert Tilg,et al.  Adipocytokines: mediators linking adipose tissue, inflammation and immunity , 2006, Nature Reviews Immunology.

[48]  R. Kitazawa,et al.  MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. , 2006, The Journal of clinical investigation.

[49]  Z. Kis,et al.  Elevated antibody levels against Chlamydia pneumoniae, human HSP60 and mycobacterial HSP65 are independent risk factors in myocardial infarction and ischaemic heart disease. , 2004, Atherosclerosis.

[50]  M. Desai,et al.  Obesity is associated with macrophage accumulation in adipose tissue. , 2003, The Journal of clinical investigation.

[51]  L. Tartaglia,et al.  Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. , 2003, The Journal of clinical investigation.

[52]  M. Dickie,et al.  Obese, a new mutation in the house mouse. , 1950, Obesity research.

[53]  B. Spiegelman,et al.  Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. , 1993, Science.

[54]  M. Dumont,et al.  European Association for the Study of the Liver , 1971 .